SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-109424
Filing Date
2023-04-21
Accepted
2023-04-21 08:50:28
Documents
5
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A d456749ddef14a.htm DEF 14A 322183
2 GRAPHIC g456749g01a11.jpg GRAPHIC 209784
3 GRAPHIC g456749g02a22.jpg GRAPHIC 166311
4 GRAPHIC g456749g50c16.jpg GRAPHIC 51277
5 GRAPHIC g456749g56q65.jpg GRAPHIC 31419
  Complete submission text file 0001193125-23-109424.txt   955502
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38529 | Film No.: 23834699
SIC: 2834 Pharmaceutical Preparations